HAEMONETICS CORP — Director's Dealing 2018

Jan 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-01-24

Reporting Person: Zane Ellen M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-24	Common Stock	A	1301	$65.86	Acquired	1301	Direct

Footnotes

F1: Restricted Stock Unit grant which vests 100% on the first anniversary of the grant date. The grant was made under the 2005 Long Term Incentive Compensation Plan.